• 제목/요약/키워드: The liver

Search Result 13,042, Processing Time 0.123 seconds

컴퓨터단층영상에서 TIA를 이용한 간경화의 컴퓨터보조진단 (Computer-Aided Diagnosis for Liver Cirrhosis using Texture features Information Analysis in Computed Tomography)

  • 김창수;고성진;강세식;김정훈;김동현;최석윤
    • 한국콘텐츠학회논문지
    • /
    • 제12권4호
    • /
    • pp.358-366
    • /
    • 2012
  • 간경화(liver cirrhosis)는 섬유조직의 증식과 재생성 결절 형성의 형태학적인 변화로 2차적으로 간내혈관의 변형 및 간기능의 저하가 나타나는 질병이며, 정맥류, 복수와 부종, 간성뇌증, 간암 등의 합병증 동반을 미연에 방지하는 것이 간경변증 진단 및 치료에 핵심이다. 일반적으로 간 컴퓨터단층영상이 간경변의 진단 및 병기를 결정하는 방법으로 사용한다. 그러므로 본 연구에서는 간경화의 자동 인식을 위하여 PCA와 TIA 알고리즘을 이용한 특징추출을 통하여 간경변의 자동 검출능력을 알아보고, 각 알고리즘간의 성능을 비교하였다. 실험은 학습영상과 테스트영상으로 구분한다. 고유영상을 생성시키기 위한 학습영상으로 정상영상이 사용되고, 테스트영상으로는 간경화영상이 사용된다. 간 CT 영상에서 간의 질병 부위를 균등하게 ROI 설정하고, $50{\times}50$ 픽셀 크기로 영상을 저장하여 실험하였다. 실험결과로 PCA는 간경화 검출율이 35%로 질병 인식으로 부적합하며, TIA 알고리즘의 AGL, TM, MU, EN는 100% 질병 인식력을 나타내어 간경화 자동 진단 인식으로 가능했다. 또한 결과를 임상에 적용하여 간경변의 컴퓨터보조진단으로 활용한다면 영상의학과 의사에게 업무 부담을 줄이고, 일차적 간경변의 스크리닝 도구로서 활용이 가능할 것이다. 그리고 TIA 알고리즘을 활용한 자동진단은 질병 진단의 전단계로서 예비판독의 정보를 제공하며 간경변의 조기 진단 및 예방이 가능다고 판단된다.

벤지딘으로 오염된 음용수를 섭취한 흰쥐에서 간장세포와 방광세포에 형성된 발암물질- DNA adduct에 관한 연구 (Carcinogen-DNA adducts in Liver and Bladder of Sprague-Dawley rats treated with benzidine in drinking water)

  • 이진헌;신호상;장미선;홍춘표;최석남
    • 한국환경보건학회지
    • /
    • 제27권3호
    • /
    • pp.63-70
    • /
    • 2001
  • To identify and evaluate the benzidine-DNA adducts in liver and bladder, we exposed the 80 ppm benzidine to 40 sprague-dawley rats by drinking water for 4 weeks(6.2 mg/kg body wt./day). Only one benzidine-DNA adduct was found at the same site of thin layer chromatogram of $^{32}$ P-postlabeling method in the liver and bladder of exposed rats. So we know the DNA adduct formed at liver and bladder were similar to each other, which was N-(deoxyguanosin-8-yl)-N'-acetylbenzidine. Relative adduct labeling(RAL) of DNA adduct was similar to each other for 1 and 2 weeks, but that in liver was significantly higher than in bladder for 3 and 4 weeks. RAL$\times$10$^{9}$ of DNA adduct were 84.45$\pm$11.31 and 152.8$\pm$5.53 in liver, and were 24.76$\pm$7.06 and 38.00$\pm$10.57 in bladder for 3 and 4 weeks, respectively. Regression equation between liver and bladder was Y=-3.801+2.507 X(r=0.6036, p<0.01). In conclusion, benzidine-DNA adduct formed in liver was significantly higher than that in bladder, with the similar compound structure in sparague-dewley rates treated benzidine in drinking water.

  • PDF

간 질환력과 원발성 간암에 관한 환자-대조군 연구 (A Case-Control Study of Primary Liver Cancer and Liver Disease History)

  • 김동현;박병주;유근영;안윤옥;이효석;김정룡;이상일;이무송;안형식;김헌;박태수
    • Journal of Preventive Medicine and Public Health
    • /
    • 제27권2호
    • /
    • pp.217-225
    • /
    • 1994
  • The relationship between past liver disease history and the risk of primary liver cancer was analyzed in a hospital-based case-control study conducted in Seoul on 165 patients with histologically or serologically confirmed hepatocellular carcinoma and individually age- and sex-matched 165 controls in hospital for ophthalmologic, otologic, or nasopharyngeal problems. Significant association were observed for liver deseases occurring 5 or more years before liver cancer diagnosis [OR,4.9;95% confidence interval (CI), $1.6{\sim}14.0$) and family history of liver disease(OR, 9.0;95% CI, $2.1{\sim}38.8$). These associations were not appreciably modified by allowance for major identified potential confounding factors. From these results, it is possible to speculate that liver cell injuries caused by various factors might be a common pathway to developing primary liver carcinoma. Considering the significant effect of family history of liver diseases on PLCA risk after adjusting past liver disease history, there might be genetic susceptibility in the carcinogenic mechanism of liver cancer. Further investigations are needed to clarify the effect of family history of liver disease on PLCA risk.

  • PDF

소아에서 급성 간부전의 진단과 치료 (Diagnosis and Management of Acute Liver Failure in Children)

  • 심정옥
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제11권sup2호
    • /
    • pp.50-58
    • /
    • 2008
  • 급성 간부전은 여러 분야의 전문가 및 이식 센터의 협조가 필요한 질환으로 급성 간염을 보이는 모든 환자에서 급성 간부전으로 진행할 가능성에 대해 고려하여야 한다. 소아에서 급성 간부전은 원인 미상인 경우가 가장 흔하며, 영아기에는 대사성 간질환도 염두에 두어야 한다. 급성 간부전의 예후는 간이식이 도입된 이후 획기적으로 향상되었으나, 간성 뇌증, 혈액응고 장애, 감염, 신부전 등 주요 합병증에 대한 치료는 여전히 예후를 좌우하는 중요한 부분이며, 여기에 더하여 간이식의 여부 및 시기에 대한 결정이 소아과 의사의 중요한 역할 중 하나가 되었다. 원인이 밝혀진 경우에는 예후 예측에 도움이 되고, 원인에 대한 치료를 시도해볼 수 있으나 소아 환자는 원인 미상인 경우가 많아 예후 예측이 어렵고, 주 사망 원인인 간성 뇌증에 대한 평가가 어려워 특히 세심한 모니터가 필요하다.

  • PDF

국소성(局所性) 간병변(肝病變)에서 간(肝)스캔의 진단적(診斷的) 가치(價値)에 대한 분석(分析) (Evaluation of Liver Scintigraphy in Patients with Focal Liver Disease (S.O.L): An Analysis of Histologically Confirmed 401 Cases)

  • 이명철;정준기;조보연;고창순;송본철;관야지남
    • 대한핵의학회지
    • /
    • 제18권1호
    • /
    • pp.33-37
    • /
    • 1984
  • The accuracy of liver scanning was evaluated in 124 cases with primary or metastatic liver tumors, including a few benign localized lesions and in 277 cases without such lesions. All findings were histologically verified by operation or autopsy. 1) Of the 124 cases with space occupying lesions(SOLs) in the liver, 92 cases were detected by liver scan(sensitivity 74.2%). And of the 277 cases without such lesions, 266 cases were evaluated as no SOLs(specificity 96.0%). The overall accuracy was 89.3%. 2) The authors evaluated the liver scan sensitivity in each of different diseases with SOLs. The sensitivity was 88.9% in primary liver carcinoma, 82.4% in primary liver carcinoma with cirrhosis, 88.7% in liver abscess, and 100% in hemangioma. The sensitivity was low in metastatic tumor(65.8%). 3) The sensitivity of the SOLs in the right lobe was 53.3% and left lobe 27.7%. In the interlobar area, detectability was 41.7%. 4) The authors compared the sensitivity of the liver scan with the size of the SOLs. The smaller the size of the SOLs, the lower the detectability. In the pachy lesions, the sensitivity was 46.6%.

  • PDF

간염1호방(肝炎1號方)이 실험동물(實驗動物)의 급만성(急慢性) 간손상(肝損傷)에 미치는 영향(影響) (Influence of Ganyeumilhobang on Acute and Chronic Liver Injury in Experimental Animal)

  • 최수덕;김영진;김강산
    • 대한한방내과학회지
    • /
    • 제19권1호
    • /
    • pp.22-38
    • /
    • 1998
  • This study was to investigate the hepatoprotective and anticirrhotic effects of Ganyeumilhobang(GIE) on the acute and chronic liver injury induced by various agents. Chronic liver injury induced by dimethylnitrosamine(DMN) ; a new experimental model for cirrhosis and the intraperitoneal injection of dimethylnitrosamine in the rat. Acute liver njury induced by carbon tetrachloride$(CCl_4)$ and D-galactosamine ; a experimental model for acute liver injury, the administration of $CCl_4$ and the intraperitoneal injection of D-galactosamine in the rat. The development of fibrosis and acute liver injury by the three prescriptions were examined by the chemical analysis of AST, ALT, prothrombin time and hydroxyproline. The results obtained were as follows. 1. The increasing level of hydroxyproline volume induced by DMN in mice was decreased by the oral administration of GIB. 2. The degree of histological fibrosis and hepatic inflammatory cell infiltration induced by $CCl_4$ decreased by the oral administration of GIB. 3. The increase of senun AST and ALT of mice with acute liver damage induced by $CCl_4$ and D-galactosamine was inhibited by the administration of GIB. 4. The prolongation of prothrombin time(seconds) of mice acute liver damage induced by $CCl_4$ was shortened by the oral administration of GIB. 5. The liver of mice was hepatectomized partial1y after the oral administration of GIB. The mitotic index(% of nuclei), weight of liver, contents of protein, RNA and DNA synthesis of the liver tissue were increased by the oral administration of GIB.

  • PDF

Tc-99m Galactosylated Serum Albumin (GSA)을 이용한 정량적 간수용체 영상술 (Quantitative Evaluation of Liver Function with Hepatic Receptor Scintigraphy using Tc-99m Galactosylated Serum Albumin (GSA))

  • 이재태
    • 대한핵의학회지
    • /
    • 제32권4호
    • /
    • pp.305-313
    • /
    • 1998
  • The reduction in the amount of asialoglycoprotein (ASGP) receptor, which resides exclusively on the plasma membrane of functioning mammalian hepatocytes, as a consequence of hepato-cellular damage has been demonstrated in various pathologic conditions of the liver. Galac-tosylated human serum albumin (GSA) is a newly developed receptor-binding agent, specific for the ASGP receptor. Tc-99m GSA binds quantitatively to liver ASGP receptors and the rate of accumulation in the liver is dependent on hepatic function represented as the amount of receptor, as well as the amount of ligand injected, its affinity to the receptor and the hepatic blood flow. The findings of Tc-99m GSA scintigraphy were reported to reflect the hepatic function of the patients with large hepatic tumors, obstructive jaundice, acute and chronic liver disease. Tc-99m GSA scintigraphy is an easy and reliable test and has the clinical potentials to evaluate the liver function in the patients with hepatic disorders.

  • PDF

사상체질별 간기능 검사 및 초음파상의 간질환에 대한 연구 (Study on Liver Function Test and Liver Disorders under the Ultrasonography for each of the Sasang Constitutional Types)

  • 김민지;배효상;박성식
    • 사상체질의학회지
    • /
    • 제25권3호
    • /
    • pp.195-207
    • /
    • 2013
  • Objectives This study aimed to examine differences in the hepatic function disorders and prevalence rates of liver diseases in accordance with the Sasang constitutional type, and to analyze whether Sasang constitution is a significant risk factor for fatty liver. Methods A total of 1211 patients who underwent health check-up at the Ilsan Hospital of Dongguk University and had their physical constitutions diagnosed by a specialist in Sasang constitutional medicine from October 31, 2011 to September 28, 2012 were used as the subjects of this study. Presence of hepatobiliary diseases was analyzed from the results of the hepatic function test, lipid test and viral hepatitis infection marker test in the biochemistry tests, and abdominal ultrasonography. Results & Conclusion Subjects of the study were composed of 691 males and 520 females and, in terms of Sasang constitution distribution, 550 Taeeumin, 343 Soeumin and 318 Soyangin. As the results of analysis of prevalence rates in accordance with Sasang constitutions, significant differences were observed in the prevalence rates of abnormal groups in the cases of AST, ALT, GGT, Triglyceride, HDL-cholesterol and LDL-cholesterol, and all of their prevalence rates were in the descending order of Taeeumin, Soyangin and Soeumin. Soeumin displayed significantly higher positive rate for HBs Ab in comparison to Taeeumin and Soyangin. In the results of abdominal ultrasonography, the prevalence rates of fatty liver displayed significant differences and were in the descending order of Taeeumin, Soyangin and Soeumin. And as the result of logistic regression analysis in order to find the risk factors of fatty liver, the Sasang constitution was found to be a significant risk factor for fatty liver. The odds ratio of Taeeumin in fatty liver was found to be 1.634 higher than Soeumin and 1.773 higher than Soyangin

$^{113m}In$ 교질(膠質)에 의(依)한 간주사(肝走査)에 관(關)한 연구(硏究) (A Study of Liver Scan using $^{113m}In$ Colloid)

  • 고창순;이종헌;장고창;홍창기
    • 대한핵의학회지
    • /
    • 제3권1호
    • /
    • pp.83-99
    • /
    • 1969
  • There have been reported numberous cases of liver scanning in use of $^{198}Au$ colloid by many investigators, however, one in use of $^{113m}In$ colloid has not been reported as yet in this country. The dose of $^{113m}In$ for high diagnostic value in examination of each organ was determined and the dignostic interpretability of liver scanning with the use of $^{113m}In$ was carefully evaluated in comparison with the results of the liver scanning by the conventionally applied radioisotopes. The comparative study of both figures of liver scannings with the use of $^{113m}In$ colloid and $^{198}Au$ colloid delivered following results: 1. The liver uptake rate and clearance into peripheral blood were accentuated more in case of $^{113m}In$ colloid than in case of $^{198}Au$ colloid. 2. The interpretability of space occupying lesion in liver scanning with $^{113m}In$ was also superior to one with $^{198}Au$. 3. The figure of liver scanning with $^{113m}In$ colloid corresponds not always to the figure with $^{198}Au$. This difference can be explained by differences of phagocytic ability of reticuloendotherial system within liver. 4. In the liver scanning with $^{113m}In$ colloid, the spleen is also visualized even in normal examinee. 5. In the cases of disturbed liver function, uptake is more decreased in use of $^{113m}In$ colloid than in $^{198}Au$, in the spleen, however, the way is contrary. 6. With use of $^{113m}In$ colloid, the time required for scanning could be shortened in comparison with $^{198}Au$. 7. The filtration of $^{113m}In$ colloid for scanning prior to human administration gives an expectation for better scanning figure.

  • PDF

Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis

  • Faranak Salajegheh;Mohammad Rezaei Zadeh Rukerd;Mohsen Nakhaie;Zohreh-Al-Sadat Ghoreshi;Javad Charostad;Nasir Arefinia
    • Clinical and Experimental Vaccine Research
    • /
    • 제13권2호
    • /
    • pp.83-90
    • /
    • 2024
  • The emergence of coronavirus disease 2019 (COVID-19) vaccines has been a remarkable advancement. However, the efficacy, immunogenicity, and safety of these vaccines in individuals with liver cirrhosis require careful evaluation due to their compromised immune status and potential interactions with underlying liver disease. The present study aimed to evaluate the safety and efficacy of COVID-19 vaccines in liver cirrhosis patients. In the present study, we searched international databases, including Google Scholar, PubMed, Scopus, Embase, and Web of Science. The search strategy was carried out by using keywords and MeSH (Medical Subject Headings) terms. STATA ver. 15.0 (Stata Corp., USA) was used to analyze the data statistically. The analysis was performed using the randomeffects model. We also used the chi-square test and I2 index to calculate heterogeneity among studies. For evaluating publication bias, Begg's funnel plots and Egger's tests were used. A total of 4,831 liver cirrhosis patients with COVID-19 were examined from 11 studies. The rate of hospitalization in the patients with liver cirrhosis was 17.6% (95% confidence interval [CI], 9%-44%). The rate of fever in the patients with liver cirrhosis was 4.5% (95% CI, 0.9%-8.1%). The rate of positive neutralizing antibodies in the patients with liver cirrhosis was 82.5% (95% CI, 69.8%-95.1%). Also, the rates of seroconversion after the second vaccination in patients with liver cirrhosis and the control group were 96.6% (95% CI, 92.0%-99.0%), and 99.7% (95% CI, 99.0%-100.0%), respectively. COVID-19 vaccines have demonstrated promising efficacy, immunogenicity, and safety profiles in individuals with liver cirrhosis, providing crucial protection against COVID-19-related complications.